Deals
Perrigo Shares Gain After Report Drugmaker Is Close to Deal
- StreetInsider reports deal could be worth about $20 billion
- Spokeswoman for company declines to comment on news report
Perrigo Said to Be Nearing Deal
This article is for subscribers only.
Perrigo Co., a maker of generic and over-the-counter drugs, surged Tuesday after a report by StreetInsider.com that it was nearing a deal to be acquired for about $20 billion by a U.K.-based firm.
The shares rose 9.2 percent to $108.13, the biggest one-day gain since April 2015. StreetInsider cited a person familiar with the matter, without identifying them. The outlet didn’t name the company it said could buy Perrigo.